Microcrystalline Cellulose (MCC) Market Size & Insights:
The global microcrystalline cellulose (MCC) market size was valued at $401.1 million in 2021, and is projected to reach $712.9 million by 2031, growing at a CAGR of 5.9% from 2022 to 2031.
Introduction
Microcrystalline cellulose (MCC) is a refined, partially depolymerized form of cellulose derived from natural sources such as wood pulp or plant fibers. It is an odorless, tasteless, and chemically inert white powder known for its high degree of purity and crystallinity. Widely used as an excipient in pharmaceuticals, MCC serves as a binder, filler, and disintegrant in tablet formulations. It also finds applications in food, cosmetics, and industrial products due to its excellent compressibility, moisture absorption, and stability. Its non-toxic nature, biodegradability, and functional versatility make it a valuable ingredient across various industries.
One of the most prominent sectors utilizing MCC is the pharmaceutical industry. MCC functions as a superior excipient, a substance formulated alongside the active ingredient of a medication to support the manufacturing process and enhance performance. In tablet formulation, MCC acts as a binder, filler, and disintegrant. Its compressibility allows manufacturers to produce tablets with high mechanical strength without the need for excessive pressure, which helps preserve sensitive active pharmaceutical ingredients (APIs).
Key Takeaways:
Microcrystalline cellulose report includes list of top consumers, production capacities of manufacturers, top customers country wise, and highest price and lowest price from each country of production and the company name that commands highest and lowest price.
The global microcrystalline cellulose market has been analyzed in terms of value ($million) and volume (Tons). The analysis in the report is provided on the basis of source type, drying process, application, 4 major regions, 23 companies, and more than 20 countries.
Key manufacturers such as Asahi Kasei Chemicals Corporation, Roquette, and DFE Pharma is actively engaged in product launches, acquistion, and business expansion key developments for a better understanding of microcrystalline cellulose (MCC) market.
Latest trends such as high R&D investment in the synthesis process of microcrystalline cellulose is expected to boost the microcrystalline cellulose market growth. For instance, clinical research is going on a new microcrystalline cellulose dietetic supplement which would have a massive impact on global microcrystalline cellulose (MCC) market growth.
Market Dynamics
The growing demand for microcrystalline cellulose (MCC) in pharmaceuticals is expected to drive the growth of the microcrystalline cellulose (MCC) market. Microcrystalline cellulose (MCC) plays a critical role in the pharmaceutical industry, primarily as a binder, filler, and disintegrant in tablet formulations. Its excellent compressibility and flow properties make it ideal for direct compression processes, which are commonly used in tablet manufacturing. MCC not only helps in forming tablets with the desired hardness and stability but also ensures consistent drug delivery and efficacy, which are crucial to maintaining therapeutic standards. The Indian government has projected the country's pharmaceutical industry to reach a market size of $130 billion by 2030, emphasizing the need for high-quality excipients like microcrystalline cellulose (MCC) to support this expansion. Moreover, in September 2023, Nitika Pharmaceuticals inaugurated India's largest MCC manufacturing plant in Nagpur, aiming to meet the growing domestic demand for pharmaceutical-grade excipients.
However, high production cost is expected to restrain the growth of the microcrystalline cellulose (MCC) market. The production of microcrystalline cellulose (MCC) involves several complex and energy-intensive steps that contribute to its relatively high manufacturing cost. The process begins with the extraction of purified cellulose from raw materials such as wood pulp or cotton linters. This cellulose is then subjected to controlled acid hydrolysis to break down the long cellulose chains into smaller, crystalline particles. These steps require precise control and specialized equipment to ensure the quality and consistency of the final MCC product. In addition, the energy consumption during these processes is significant, further driving the production costs. The need for stringent quality control measures, including washing, drying, and milling, also adds to the overall expense.
Moreover, innovation in drug delivery systems is expected to provide lucrative opportunities in the microcrystalline cellulose (MCC) market. Microcrystalline cellulose (MCC) is increasingly recognized for its versatility and compatibility with advanced oral drug delivery systems, particularly orally disintegrating tablets (ODTs). ODTs are designed to dissolve quickly in the mouth without the need for water, providing a convenient option for patients who have difficulty swallowing traditional tablets, such as children and the elderly. MCC’s excellent binding properties and ability to improve tablet hardness while maintaining rapid disintegration make it an ideal excipient for these formulations. Oramed Pharmaceuticals is conducting Phase 3 trials for its oral insulin capsule aimed at treating type 2 diabetes. In May 2023, the company announced that the insulin pill was approved in China and plans to collaborate with a Chinese firm to apply for marketing authorizations.
Segment Overview:
The microcrystalline cellulose market is segmented on the basis of source type, drying process, application, and region. By source type, it is bifurcated into wood- and non-wood-based. By drying process, the market is categorized into bulk-drying and spray drying. By application, it is divided into pharmaceutical, food & beverage, cosmetics & personal care, and others. Region-wise, the microcrystalline cellulose market (MCC) marketis is studied across North America, Europe, Asia-Pacific, and LAMEA.
By Region
Europe would exhibit highest CAGR of 5.5% during 2022-2031.
Europe would exhibit the highest CAGR of 5.5% during 2022-2031
On the basis of region, Europe accounted for a major market share in 2021 with a 5.5% share in the global microcrystalline cellulose market and is projected to grow at the highest CAGR during the forecast period. In the pharmaceutical sector, Europe is one of the largest consumers of microcrystalline cellulose due to its indispensable role in tablet formulation. MCC acts as a binder, filler, and disintegrant in tablet production, providing the necessary mechanical strength and ensuring tablets disintegrate properly in the digestive tract. The increasing prevalence of chronic diseases and the growing aging population in Europe have resulted in higher demand for oral solid dosage forms, which in turn fuels the consumption of MCC. Moreover, stringent regulatory requirements around drug safety and efficacy emphasize the use of high-quality excipients like MCC, which comply with European Pharmacopeia standards. European manufacturers are focusing on sustainable and bio-based MCC production. Companies like JRS Pharma are investing in organic and plant-derived cellulose solutions, aligning with the growing consumer preference for eco-friendly and biodegradable ingredients.
By Source Type
Wood based source type segment is the most lucrative segment
By Source Type
On the basis of type, the wood-based segment was the largest revenue generator, and is anticipated to grow at a CAGR of 8.5% during the forecast period. Microcrystalline cellulose (MCC) is a refined, partially depolymerized form of cellulose derived primarily from plant fibers, including wood pulp. It is widely recognized for its versatile applications across various industries, particularly in pharmaceuticals, food, and cosmetics. The primary use of MCC in wood-based industries is in the manufacture of composite materials. Wood composites, such as fiberboard, particleboard, and medium-density fiberboard (MDF), are often enhanced by incorporating MCC to improve mechanical strength and dimensional stability. The high surface area and strong hydrogen bonding capacity of MCC enable better interfacial adhesion between wood fibers and polymeric binders or resins.
By Drying Process
Spray Drying process is expected as fastest growing segment
By Drying Process
On the basis of drying process, spray drying process dominated the microcrystalline cellulose market in 2021. Microcrystalline cellulose acts as a stabilizer and binder during spray drying. Due to its excellent water retention and gel-forming capabilities, MCC helps in maintaining the integrity of the dried particles. When a solution or suspension containing active ingredients is spray-dried, MCC can prevent the particles from sticking together, which reduces agglomeration and caking in the final powder. This effect improves the flowability and dispersibility of powders, which is critical for downstream processing such as tablet compression or capsule filling in pharmaceuticals, as well as for uniform mixing in food formulations. Asahi Kasei Corporation completed the construction of its second Ceolus™ MCC plant in Kurashiki, Japan, in January 2023. This expansion aims to meet the growing demand for MCC in pharmaceutical applications which is gaining popularity for spray drying process.
By Application
Pharmaceutical application segment is projected as the fastest growing segment
By Application
On the basis of application, the pharmaceutical segment dominated the global microcrystalline cellulose market, in terms of revenue in 2021 with more than one-third of the market share. MCC’s excellent compressibility makes it highly suitable for direct compression tablet manufacturing, a process that is simpler and more cost-effective than wet granulation. Direct compression involves compressing powder mixtures directly into tablets without the need for moisture or heat, and MCC facilitates this by providing good flow and binding properties under pressure. This reduces manufacturing complexity and improves production efficiency. In addition, MCC is chemically inert and non-reactive with most drugs, which helps preserve the stability and bioavailability of APIs in the formulation. JRS Pharma GmbH & Co. KG introduced a new grade of MCC, Avicel® HFE Pro, in September 2023. This high-performance MCC is designed to meet the demanding requirements of the pharmaceutical industry, suitable for various applications including tablet and capsule formulations.
Competitive Analysis:
The major companies profiled in the microcrystalline cellulose market report include DowDupont Inc., FMC Corporation, Asahi Kasei Chemicals Corporation, Accent Microcell Pvt. Ltd, JRS PHARMA GmbH and Co. KG, Ming Tai Chemical Co. Ltd, Foodchem International Corporation, Maple Biotech Pvt. Ltd., Chemfield Cellulose, NB Entrepreneurs, Cellutech Pharma, Quadra Chemicals., Ankit Pulps, Roquette, Sigachi Industries Pvt. Ltd, Huzhou City LinghuXinwang Chemical Co., Ltd, Amishi Drugs And Chemicals Pvt Ltd, ASHOK CHEM–PHARMA, Anhui Shanhe Pharmaceutical Excipients Co., Ltd., DFE Pharma.
Recent Key Strategies and Developments in the Microcrystalline Cellulose Market
In November 2022, DFE Pharma collaborated with Azelis, a leading service provider in the specialty chemicals and food ingredients sector, to distribute its products across the EMEA region.
In February 2023, Asahi Kasei Corporation completed the construction of its second manufacturing plant dedicated to Ceolus Microcrystalline Cellulose at its Mizushima Works in Kurashiki, Okayama, Japan. The company invested a total of $87 million (¥13 billion). With the new facility, the company underlines its commitment to meet the substantially growing demand for its MCC.
In October 2023, Roquette Frères announced the addition of three new excipient grades to its unmatched portfolio of solutions for moisture-sensitive active pharmaceutical and nutraceutical ingredients. Unveiled on-stand at CPHI Barcelona, LYCATAB® CT-LM partially pregelatinized starch, MICROCEL® 103 SD, and MICROCEL® 113 SD microcrystalline cellulose offers a unique range of stabilizing and moisture protective benefits, giving pharmaceutical manufacturers the tools they need to optimize any drug delivery, regardless of production method or formulation type.
In May 2024, Roquette announced the introduction of its new LYCAGEL® Flex hydroxypropyl pea starch premix, which will be used for nutraceutical and pharmaceutical softgel capsules. Roquette is the leading provider of pharmaceutical and nutraceutical excipients.
In January 2025, the European Commission authorized microcrystalline cellulose, along with other cellulose derivatives, as feed additives for all animal species. This authorization, valid until 2035, highlights the EU's recognition of MCC's safety and efficacy in various applications.
Key Benefits For Stakeholders:
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the microcrystalline cellulose (mcc) market analysis from 2021 to 2031 to identify the prevailing microcrystalline cellulose market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the microcrystalline cellulose (mcc) market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global microcrystalline cellulose market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global microcrystalline cellulose (mcc) market trends, key players, market segments, application areas, and market growth strategies.
Microcrystalline Cellulose (MCC) Market Report Highlights
| Aspects | Details |
 Market Size By 2031 | USD 712.9 million |
 Growth Rate | CAGR of 5.9% |
 Forecast period | 2021 - 2031 |
 Report Pages | 456 |
 By Source Type |
|
 By Drying Process |
|
 By Application |
|
 By Region |
|
 Key Market Players | Ankit Pulps, Maple Biotech Pvt. Ltd., Roquette, Accent Microcell Pvt. Ltd, Sigachi Industries Pvt. Ltd, Huzhou City LinghuXinwang Chemical Co., Ltd, Foodchem International Corporation, NB Entrepreneurs, Amishi Drugs And Chemicals Pvt Ltd, Cellutech Pharma, Asahi Kasei Chemicals Corporation, Ming Tai Chemical Co. Ltd, ASHOK CHEM –PHARMA, DowDupont Inc., JRS PHARMA GmbH and Co. KG, FMC Corporation, DFE Pharma, Chemfield Cellulose, Anhui Shanhe Pharmaceutical Excipients Co., Ltd., Quadra Chemicals. |
Analyst Review
According to CXOs of leading companies, the global microcrystalline cellulose market is expected to exhibit high growth potential. Microcrystalline cellulose is widely used in food & beverages, pharmaceuticals, and cosmetics. It is an excellent source of binders, texturizers, emulsifiers, abrasives, and extenders. The market is influenced by the inflated cost of raw materials and processing methods, thereby increasing the cost of microcrystalline cellulose. This factor is expected to impede the growth of the market. However, Asia-Pacific has witnessed significant adoption of microcrystalline cellulose in various industries such as food & beverages and cosmetics during the forecast period.??
In addition, distinct types of microcrystalline cellulose are used as texturizers in the growing textiles industry. Furthermore, factors such as flexibility in operation, ease of application, and sustainability have enhanced the performance of microcrystalline cellulose in several end-use industries. CXOs further added that sustained economic growth and development of the pharmaceutical sector have increased the popularity of microcrystalline cellulose.?
Microcrystalline cellulose is a non-caloric purified form of cellulose, which is used as a bulking, anti-caking, and emulsifying agent. This cellulose is derived from high quality wood pulp. It is widely used in the pharmaceutical industry as a binder or diluent in the formulation of tablets and capsules. It can be used in both wet-granulation and direct-compression processes of tablet formation. This cellulose can be consumed as a natural source of dietary fiber In the food & beverage industry, it is used as an anti-caking agent, texture modifier, suspending agent, and stabilizer. It is mostly found in processed food and is ideally a healthy food additive. It helps in providing a creamy texture to dairy products without any addition of fat.?
DowDupont Inc., FMC Corporation, Asahi Kasei Chemicals Corporation, JRS PHARMA GmbH and Co. KG, Ankit Pulps, Roquette, Sigachi Industries Pvt. Ltd, Anhui Shanhe Pharmaceutical Excipients Co., Ltd., DFE Pharma.
Europe is the largest regional market for mcc market.
The microcrystalline cellulose market is segmented on the basis of source type, drying process, application, and region. By source type, it is bifurcated into wood- and non-wood-based. By drying process, the market is categorized into bulk-drying and spray drying. By application, it is divided into pharmaceutical, food & beverage, cosmetics & personal care, and others. Region-wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.
Pharmaceutical application segment is the leading segment in microcrystalline cellulose market.
The global microcrystalline cellulose (MCC) market was valued at $401.1 million in 2021, and is projected to reach $712.9 million by 2031, growing at a CAGR of 5.9% from 2022 to 2031.
Expansion of Phamaceutical, food and beverages units, and growing consumer demand for microcrystalline cellulose-based products is the upcoming trend for mcc market.
Loading Table Of Content...
Loading Research Methodology...
